Reshaping Gene Therapy
The Team
James Lynch
Chief Executive Officer
Patrick Halley
Chief Technology Officer
Chris Lucas
Chief Science Officer
Larry Beaver
Director of Finance
Carolyn Cheney
Senior Scientist
Quincy Bizjak
Research Engineer - Process Development
Mitra Bhattacharyya
Senior Scientist - Mol Bio
Carlos Castro
Director of Innovation
Shilpa Nagaraju
Consultant - Molecular Biology
Elijah Stacy
Consultant - Rare Disease
Khalid Parris
Research Engineer - Cloning and Scaffold
Board of Directors
James Lynch
Board Member
Adel Mikhail
Board Member
Gary Booth
Board Member
Chris Lucas
Board Member
Patrick Halley
Board Member
Scientific Advisory Board
Carlos Castro
SAB Chairman, Nanotechnology
John Byrd
SAB, Clinical Development
Enrique Lin-Shiao
SAB, Rare Disease
Discover the minds behind DNA Nanobots, a powerhouse team with unrivaled DNA Nanotechnology expertise. Our diverse backgrounds in science, engineering, and business converge to create groundbreaking solutions in cancer therapy and cellular research. Trust in a team that’s at the forefront of innovative medical technologies, guiding the future of precision therapeutics.
let’s get connected
Have a Question?
You know you want to talk about nanobots with us.